RedCarpetLife
1497
In the world today
Wu Guanjiang

Wu Guanjiang

W. Guanjiang
-0.14% | - $-3.80M
$2.76 B ₹ 25,113 Cr
Real Time Net Worth #1497 Ranking as of 21 Feb 2026 By Forbes

More on Wu Guanjiang

Gender

Male

Age

58Y

Country

China

Born On

January, 1968

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Healthcare)

Primary Organization

Chongqing Zhifei Biological Products

Titles

Co-Founder

Sources of Wealth

Vaccines

Industry

Healthcare, Pharmaceuticals

About Wu Guanjiang


W u Guanjiang is a co-founder of Chongqing Zhifei Biological Products, one of China's largest private vaccine manufacturers. He served as the company's chairman during its formative years, guiding it through critical growth phases and its successful initial public offering on the Shenzhen Stock Exchange in 2010. Zhifei is known for distributing Merck's HPV vaccines in China as well as developing its own proprietary vaccines.

Over the years, Wu has gradually stepped back from the company's day-to-day operations and has sold a significant portion of his shares, diversifying his wealth. Although he no longer holds a management role and his stake has dipped below 5%, the proceeds from his equity sales have cemented his financial standing. He remains a notable figure in the history of China's biotech industry.

Advertisement

Quick Reads


Early Life and Background


Wu Guanjiang is a Chinese businessman, a cofounder of Chongqing Zhifei Biological Products (SZSE: 300122), a major vaccine maker.

Wu, who was previously chairman, has since gradually reduced his stake in the company and no longer has a management role. His wealth is primarily comprised of the proceeds from the sale of his shares over the years.

  • Core Company: Chongqing Zhifei Biological Products (Vaccine maker).
  • Key Role: Cofounder and former chairman.
  • Ownership: His stake in Zhifei is now less than 5%.

Career Journey of Wu Guanjiang


Wu Guanjiang's career is defined by his foundational role in establishing one of China's leading vaccine manufacturers. His structural achievement is tied to co-founding Zhifei, which successfully listed on the Shenzhen Stock Exchange in 2010.

Following the company's public offering, Wu progressively divested his holdings. His fortune is secured by these liquid assets, as he gradually reduced his stake to less than 5% and no longer has a management role.

  • IPO: Listed on the Shenzhen Stock Exchange in 2010.

Advertisement

Wu Guanjiang's Timeline


Ongoing:

Cofounded Chongqing Zhifei Biological Products and served as chairman.

2010:

Zhifei listed on the Shenzhen Stock Exchange.

Ongoing:

Gradually reduced his stake and exited management.

Major Business Ventures and Investments


Wu Guanjiang's wealth is concentrated in the liquid proceeds from the sale of his founding equity in the publicly traded pharmaceutical giant, Chongqing Zhifei Biological Products.

  • Chongqing Zhifei (Cofounder): Vaccine maker.
  • Current Status: No longer has a management role; wealth is from share sales.
  • Sector Focus: Pharmaceuticals, biotechnology, and vaccine manufacturing.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is the cofounder of Chongqing Zhifei Biological Products, a vaccine maker.
  • His fortune is primarily from the sale of his shares over the years.
  • He no longer has a management role in the company, and his stake is less than 5%.
  • Zhifei listed on the Shenzhen Stock Exchange in 2010.

Advertisement

More Profiles


Jean-Michel Besnier

+0.81% | +$86.70M

Antonio Percassi

+0.21% | +$2.85M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content